Published in Adv Exp Med Biol on January 01, 1993
Dealing with the family: CD147 interactions with cyclophilins. Immunology (2006) 1.46
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS One (2014) 0.80
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology (2011) 4.25
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology (2008) 2.29
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology (1984) 1.69
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol (1996) 1.64
Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease. J Exp Med (1981) 1.60
Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. J Immunol Methods (1984) 1.58
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology (2007) 1.56
Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol (1996) 1.55
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol (1989) 1.55
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology (1997) 1.54
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med (1985) 1.46
Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature (1982) 1.46
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J Neuroimmunol (1981) 1.39
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group. Neurology (1994) 1.27
A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology (1984) 1.24
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8. J Neuroimmunol (1984) 1.18
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity (1993) 1.18
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS. Neurology (1999) 1.12
Host genetic control of mouse hepatitis virus type 4 (JHM strain) replication. I. Restriction of virus amplification and spread in macrophages from resistant mice. J Gen Virol (1984) 1.12
Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology (1995) 1.10
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05
Delayed, relapsing experimental allergic encephalomyelitis in mice. J Immunol (1981) 1.03
Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. Am J Pathol (1982) 1.02
Host genetic regulation of acute MHV-4 viral encephalomyelitis and acute experimental autoimmune encephalomyelitis in (BALB/cKe x SJL/J) recombinant-inbred mice. J Neuroimmunol (1985) 1.02
Molecular cloning and characterization of an inner ear-specific structural protein. Science (1995) 1.00
Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice. Immunogenetics (1986) 0.97
Mitochondrial DNA mutations in multiple sclerosis. Mult Scler (1995) 0.96
Improved intracranial lesion characterization by tissue segmentation based on a 3D feature map. Magn Reson Med (1997) 0.95
Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. Clin Immunol Immunopathol (1987) 0.95
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler (2010) 0.94
The genetics of multiple sclerosis. A review. Biomed Pharmacother (1999) 0.92
Epitope-specific antibody response to murine hepatitis virus-4 (strain JHM). J Immunol (1985) 0.92
Nonuniformity of the oligodendroglial ensheathment of axons during myelination in the developing rat central nervous system. A serial section electron microscopical study. J Ultrastruct Res (1976) 0.90
Peripheral neuropathy in the Twitcher mutant. A new experimental model of endoneurial edema. Lab Invest (1983) 0.89
In vivo and in vitro models of demyelinating diseases. V. Comparison of the assembly of mouse hepatitis virus, strain JHM, in two murine cell lines. Intervirology (1982) 0.89
Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein. Oncogene (1996) 0.89
Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci U S A (1986) 0.88
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up. J Interferon Res (1993) 0.88
The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis. J Clin Psychol (1992) 0.88
Organ specific endothelial cell heterogeneity influences differential replication and cytopathogenicity of MHV-3 and MHV-4. Implications in viral tropism. Adv Exp Med Biol (1995) 0.87
Oligodendroglial ensheathment of axons during myelination in the developing rat central nervous system. A serial section electron microscopical sttudy. J Ultrastruct Res (1974) 0.87
Expression of the myelin basic protein gene in transgenic mice expressing human neurotropic virus, JCV, early protein. Virology (1994) 0.86
Acute and persistent viral infections of differentiated nerve cells. Rev Infect Dis (1983) 0.85
Infusion-related hypersensitivity reactions during natalizumab treatment. Neurology (2006) 0.85
Characterization of the mitochondrial DNA in patients with multiple sclerosis. J Neurol Sci (1996) 0.84
Inverse ocular bobbing. Ann Neurol (1981) 0.83
Bidirectionality in the tongue processes of the oligoendroglial cell investment of axons in the albino rat. Am J Anat (1972) 0.83
Mouse hepatitis virus type 4 infection of primary glial cultures from genetically susceptible and resistant mice. Infect Immun (1983) 0.83
Relapsing experimental allergic encephalomyelitis. An autoimmune model of multiple sclerosis. Springer Semin Immunopathol (1985) 0.83
Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV-4 infection. J Neuroimmunol (1989) 0.83
Proof of concept studies for tissue-protective agents in multiple sclerosis. Mult Scler (2009) 0.83
Adoptive transfer of murine relapsing experimental allergic encephalomyelitis. Ann Neurol (1985) 0.83
Reflex sympathetic dystrophy revisited: MR imaging findings before and after infusion of contrast material. Radiology (1995) 0.83
Mouse hepatitis virus (MHV-4, JHM) blocks gamma-interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells. J Neuroimmunol (1991) 0.82
Syringoencephalomyelia (syringocephalus). J Neuropathol Exp Neurol (1981) 0.82
Hydrocephalus in Kartagener's syndrome. Ear Nose Throat J (1986) 0.82
Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol (1993) 0.82
T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats. J Exp Med (1989) 0.82
Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis. J Clin Lab Immunol (1984) 0.82
Central nervous system and blood lymphocytes in experimental allergic encephalomyelitis. J Clin Lab Immunol (1983) 0.82
Delayed, relapsing experimental allergic encephalomyelitis in mice. Role of adjuvants and pertussis vaccine. J Neurol Sci (1983) 0.81
Relapsing experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice. Clin Exp Immunol (1986) 0.81
Genetic regulation of susceptibility and severity of demyelination. Ann N Y Acad Sci (1988) 0.81
Palliative care in patients with multiple sclerosis. Neurol Clin (2001) 0.80
Myokymia and impaired muscular relaxation with continuous motor unit activity. J Neurol Neurosurg Psychiatry (1979) 0.80
Effects of staphylococcal enterotoxin B on T cell receptor V beta utilization and clinical manifestations of experimental allergic encephalomyelitis. J Neuroimmunol (1993) 0.80
Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis. Mult Scler (1997) 0.79
Immunomodulation of relapsing experimental allergic encephalomyelitis. Neurology (1984) 0.79
Meningeal carcinomatosis complicating gynecologic malignancies: a literature review and report of a case. Obstet Gynecol Surv (1983) 0.79
Lower extremity motor evoked potentials in multiple sclerosis. Arch Neurol (1991) 0.79
Neuroimmunology: modulation of the hamster immune system by photoperiod. Life Sci (1987) 0.79